Hospices Civils de Lyon
1,963
311
351
1,043
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.0%
99 terminated/withdrawn out of 1963 trials
91.3%
+4.8% vs industry average
6%
121 trials in Phase 3/4
0%
3 of 1043 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1963)
Health-economic Assessment of Robot-assisted Bariatric Surgery
Role: lead
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)
Role: lead
Circadian Rhythmicity During Coma Awakening
Role: lead
Evaluating Facial Skin Quality Changes Post-Lipofilling
Role: collaborator
Tongue Muscular Assessment in Children With Sleep Disordered Breathing
Role: lead
Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.
Role: collaborator
Nephroprotection in Severe Trauma Patients With Kidney Stress
Role: lead
Decoding Motor Imagery From Non-invasive Brain Recordings as a Prerequisite for Innovative Motor Rehabilitation Therapies
Role: lead
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
Role: lead
Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery
Role: lead
Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)
Role: lead
Phosphorus-31 Spectroscopy in Phosphate Diabetes
Role: lead
Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
Role: lead
STETHO'TOP Study: Evaluation of the Impact of Potential Optimization Techniques on General Self-Efficacy Among Nursing Students Throughout Their Educational Curriculum
Role: lead
Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma
Role: lead
Monitoring of Septic Shock-induced Immunosuppression
Role: lead
Septic Shock-induced Immunosuppression
Role: lead
In Vivo Noradrenergic System and Aging
Role: lead
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients
Role: lead
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
Role: collaborator